The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Diagnosis: Myopathy

Diagnosis: Myopathy

July 1, 2009 • By Edward C. Smith, MD, and Dwight D. Koeberl, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The rheumatologist is frequently called upon to evaluate patients with complaints of myalgia, muscle cramping, and fatigue. Because these symptoms may be nonspecific and lack any clear temporal or anatomic pattern, their workup may entail costly and uninformative tests. When similar symptoms emerge during or following physical exertion, a metabolic myopathy should be suspected. Recurrent myoglobinuria, exercise intolerance, and mild fixed proximal muscle weakness are also frequently encountered in metabolic myopathies. Although inflammatory myopathies may present in a similar fashion, such a pattern should prompt a thorough evaluation for an underlying metabolic myopathy. This review will discuss an approach to the diagnosis and treatment of several of the more common metabolic myopathies.

You Might Also Like
  • Metabolic Myopathies
  • 2015 ACR/ARHP Annual Meeting: How to Identify, Manage Metabolic Myopathies & Their Mimics
  • ACR 2013 State-of-the-Art Clinical Symposium: How to Identify Signs of Myositis and Metabolic Myopathies
Explore This Issue
July 2009
Light micrograph of a neuromuscular junction.
Light micrograph of a neuromuscular junction.

Metabolic Myopathies

The metabolic myopathies are a heterogeneous group of disorders that share the common feature of inadequate production of cellular energy in the muscle. (See Table 1, p. 16, for a summary of metabolic myopathy classification.) They are often categorized into hereditary (primary) disorders, the focus of this review, and acquired (secondary) disorders. A further clinical distinction can be made between those disorders associated with primarily dynamic features (e.g., transient, exercise-induced fatigue, cramping, and rhabdomyolysis) and those disorders associated with primarily static features (fixed weakness).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A detailed review of muscle energy metabolism is beyond the scope of this review, but a brief consideration of the pertinent metabolic pathways is useful to better understand this group of disorders. Under normal circumstances, energy for skeletal muscle function in the form of adenosine triphosphate (ATP) is derived from muscle glycogen, blood glucose, and free fatty acids.1 Each of these primary energy sources is metabolized through specific biochemical pathways into the final common product, ATP. The majority of fuel for muscle is provided by carbohydrates in the form of glycogen and by lipids in the form of free fatty acids. Through the process of anaerobic glycolysis, glycogen is metabolized to pyruvate inside the muscle cells. Pyruvate is then decarboxylated into acetyl-coenzyme A (acetyl-CoA) inside the mitochondria. Similarly, b-oxidation of free fatty acids (fatty acid oxidation; FAO) inside mitochondria provides another source of acetyl-CoA. Acetyl-CoA then enters the Krebs cycle, generating reduced electron carriers that deliver electrons to the mitochondrial electron transport chain, thus driving the production of energy in the form of ATP. Defects in any one of the steps involved in this complex metabolic pathway can lead to an insufficient supply of ATP and an inability to sustain normal muscle function.

Pages: 1 2 3 4 5 6 7 8 | Single Page

Filed Under: Conditions, Soft Tissue Pain Tagged With: Diagnosis, myalgia, Myopathy, Pain, TreatmentIssue: July 2009

You Might Also Like:
  • Metabolic Myopathies
  • 2015 ACR/ARHP Annual Meeting: How to Identify, Manage Metabolic Myopathies & Their Mimics
  • ACR 2013 State-of-the-Art Clinical Symposium: How to Identify Signs of Myositis and Metabolic Myopathies
  • New Approaches to Inflammatory Myopathy

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.